Bundle Practices and Ventilator-Associated Events: Not Enough

Infection Control and Hospital Epidemiology

Volumn 37, Issue 12, 2016, Pages 1453-1457

  O'Horo, John C ^a   Lan, Haitao ^a,b   Thongprayoon, Charat ^a   Schenck, Louis ^a   Ahmed, Adil ^c   Dziadzko, Mikhail ^a  

^a MAYO CLINIC   (United States)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c North Central Texas Medical Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTICOAGULANT AGENT; CHLORHEXIDINE; OPIATE; SEDATIVE AGENT; MOUTHWASH;

ADULT; AGED; ANTICOAGULANT THERAPY; APACHE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENDER; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MOUTH HYGIENE; PATIENT COMPLIANCE; PEPTIC ULCER; PRACTICE GUIDELINE; PROPHYLAXIS; RETROSPECTIVE STUDY; SEDATION; STRESS ULCER; THROMBOSIS PREVENTION; VENTILATOR; VENTILATOR ASSOCIATED EVENT; VENTILATOR ASSOCIATED PNEUMONIA; ADVERSE DEVICE EFFECT; INTENSIVE CARE; MECHANICAL VENTILATOR; MIDDLE AGED; MINNESOTA; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SENTINEL SURVEILLANCE; TERTIARY CARE CENTER;

AGED; APACHE; CHLORHEXIDINE; CRITICAL CARE; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; MOUTHWASHES; PNEUMONIA, VENTILATOR-ASSOCIATED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SENTINEL SURVEILLANCE; TERTIARY CARE CENTERS; VENTILATORS, MECHANICAL;

EID: 85000578243     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2016.207     Document Type: Article

References (23)

1. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
2. Berenholtz SM, Pham JC, Thompson DA, et al. Collaborative cohort study of an intervention to reduce ventilator-associated pneumonia in the intensive care unit. Infect Control Hosp Epidemiol 2011;32:305-314.
3. Eom JS, Lee MS, Chun HK, et al. The impact of a ventilator bundle on preventing ventilator-associated pneumonia: a multicenter study. Am J Infect Control 2014;42:34-37.
4. Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol 2012;33:250-256.
5. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33:2184-2193.
6. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:1312-1317.
7. Magill SS, Klompas M, Balk R, et al. Developing a new, national approach to surveillance for ventilator-associated events. Am J Crit Care 2013;22:469-473.
8. Klein Klouwenberg PM, van Mourik MS, Ong DS, et al. Electronic implementation of a novel surveillance paradigm for ventilator-associated events: feasibility and validation. Am J Respir Crit Care Med 2014;189:947-955.
9. McMullen KM, Boyer AF, Schoenberg N, BabcockHM,Micek ST, Kollef MH. Surveillance versus clinical adjudication: differences persist with new ventilator-associated event definition. Am J Infect Control 2015;43:589-591.
10. Klompas M, Kleinman K, Khan Y, et al. Rapid and reproducible surveillance for ventilator-associated pneumonia. Clin Infect Dis 2012;54:370-377.
11. Bouadma L, Sonneville R, Garrouste-Orgeas M, et al. Ventilatorassociated events: prevalence, outcome, and relationship with ventilator-associated pneumonia. Crit Care Med 2015;43:1798-1806.
12. Centers for Disease Control and Prevention. Device module: ventilator associated events. National Healthcare Safety Network (NHSN): NHSN Patient Safety Component Manual, 2016.
13. Herasevich V, Pickering BW, Dong Y, Peters SG, Gajic O. Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness. Mayo Clin Proc 2010;85:247-254.
14. Lan H, Thongprayoon C, Ahmed A, et al. Automating quality metrics in the era of electronicmedical records: digital signatures for ventilator bundle compliance. Biomed Res Int 2015;2015:396508.
15. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model Statistics for Biology and Health. New York: Springer; 2000;xiii:350 p.
16. Li L, Ai Z, Zheng X, Jie L. Can routine oral care with antiseptics prevent ventilator-associated pneumonia in patients receiving mechanical ventilation? An update meta-analysis from 17 randomized controlled trials. Int J Clin Exp Med 2015;8:1645-1657.
17. Klompas M, Speck K, Howell MD, Greene LR, Berenholtz SM. Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med 2014;174:751-761.
18. Par M, Badovinac A, Plancak D. Oral hygiene is an important factor for prevention of ventilator-associated pneumonia. Acta Clin Croat 2014;53:72-78.
19. Krag M, Perner A, Wetterslev J, et al. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries. Acta Anaesthesiol Scand 2015;59:576-585.
20. Buendgens L, Bruensing J, Matthes M, et al. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficileassociated diarrhea. J Crit Care 2014;29:696 e611-e695.
21. Khorvash F, Abbasi S, Meidani M, Dehdashti F, Ataei B. The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients. Adv Biomed Res 2014;3:52.
22. Mehta S, Burry L, Cook D, et al. Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA 2012;308:1985-1992.
23. Sharpe JP, Magnotti LJ, Weinberg JA, et al. Gender disparity in ventilator-associated pneumonia following trauma: identifying risk factors for mortality. J Trauma Acute Care Surg 2014;77: 161-165.